Next Article in Journal
Risk Factors and Spatiotemporal Analysis of Classical Swine Fever in Ecuador
Next Article in Special Issue
Genetic Diversity of the LTR Region of Polish SRLVs and Its Impact on the Transcriptional Activity of Viral Promoters
Previous Article in Journal
Quinazolinone-Peptido-Nitrophenyl-Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease
Previous Article in Special Issue
European Brown Hare Syndrome in Poland: Current Epidemiological Situation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 15
Issue 2
10.3390/v15020289
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Epidemiology of Infectious Bursal Disease Virus in Poland during 2016–2022

by
Anna Pikuła
*,
Anna Lisowska
and
Katarzyna Domańska-Blicharz
Department of Poultry Diseases, National Veterinary Research Institute, al. Partyzantów 57, 24-100 Pulawy, Poland
*
Author to whom correspondence should be addressed.
Viruses 2023, 15(2), 289; https://doi.org/10.3390/v15020289
Submission received: 9 December 2022 / Revised: 4 January 2023 / Accepted: 17 January 2023 / Published: 19 January 2023
(This article belongs to the Special Issue State-of-the-Art Animal Virus Research in Poland II)
Browse Figures
Review Reports Versions Notes

Abstract

:
Infectious bursal disease virus is an immunosuppressive ubiquitous pathogen that causes serious economic losses in poultry production. The virus is prone to genetic changes through mutations and reassortment, which drive the emergence of new variants and lead to a change in the epidemiological situation in a field. Such a situation is currently being reported due to a large wave of IBDV A3B1 reassortant infections in northwestern Europe. On the other hand, in Poland, which is the largest producer of chicken meat in the EU, the IBDVs of genotypes A3B2 and A3B4 were circulating just before the emergence of A3B1 reassortants. The purpose of the presented study was to update the IBDV epidemiological situation. The performed molecular survey based on the sequence of both genome segments showed the presence of very virulent strains (A3B2) and reassortants of genotypes A3B4 and A3B1; moreover, two of these genotypes are newly introduced IBDV lineages. In addition, a number of amino acid substitutions were demonstrated, including within antigenic epitopes and virulence determinants. In conclusion, the results obtained indicated a dynamic epidemiological situation in Poland, which highlights the need for further monitoring studies in the region and verification of protection conferred by the vaccines used against infection with detected IBDV.

1. Introduction

The infectious bursal disease virus (IBDV) is a ubiquitous pathogen that leads to economic losses in poultry production worldwide. The virus replicates in immature B cells in the bursa of Fabricius, causing immunosuppression [1]. IBDV infection induces the so-called Gumboro disease (IBD), and the severity of the course of the disease (subclinical/acute) depends on the pathotype of the virus, the immune status, age, and the breed of the chickens [2].
IBDV is a representant of the Avibirnavirus genus within the Birnaviridae family. The virus genome is built of a double-stranded RNA divided into two segments A and B, which encodes five proteins [3]. The polycistronic segment A encodes the non-structural VP5 protein and the VP2-VP4-VP3 polyprotein, which is post-translationally cleaved by the viral protease VP4 [4]. The VP2 is the capsid protein, which contains antigenic [5] and virulence [6] determinants located within the P domain (aa 206–350). Segment B encodes viral polymerase (RdRp, VP1) responsible for replication, and transcription [7], together with the VP3 protein translation [8]; however, it also contributes to viral virulence [9]. In addition, this non-enveloped virus is highly resistant to environmental conditions, which facilitates its persistence in poultry farms and further spread.
IBDVs show genetic, pathotypic, and antigenic diversity; thus, continuous monitoring of circulating filed IBDV strains is epidemiologically important. Recently, rules have been established for IBDV genotyping based on the partial sequence of both segments [10,11], resulting in the detection of 15 IBDV genotypes. The prophylactic vaccinations of chicken flocks and maintenance of biosecurity measures are the primary tools for disease control. However, widely applied immunoprophylaxis does not effectively prevent IBDV infection, since the virus remains detected worldwide. Furthermore, the vulnerability of the virus to frequent mutations and reassortment enhanced by vaccine selection pressures contributes to virus evolution, as evidenced by the occurrence of different genotypes [12,13]. Moreover, changes in the epidemiological landscape of IBDV have been frequently observed. In China, for example, the novel A2dB1 variant strains and reassortants of the A3B3 genotype have now been detected [14]; furthermore, the variant strains have spread further into Japan and South Korea [15,16,17]. In contrast, the emergence and spread of the novel A3B1 reassortants have been reported across western Europe [18,19], while the very virulent IBDV (vvIBDV) continues to dominate in Africa [20,21], and the reassortants of the A3B5 genotype have been found in Nigeria [22]. These examples illustrate the need for the continuous monitoring of poultry flocks for IBDV infection in order to improve the effectiveness of control measures.
The aim of this study was to update the IBDV epidemiological situation in Poland in the context of the wave of infection with novel A3B1 reassortants in Europe. Furthermore, the field IBDV strains were molecularly characterized.

2. Materials and Methods

2.1. Samples

A total of 1359 samples were collected from 216 broiler and laying chicken flocks raised in 13 administrative areas of Poland for laboratory investigation between January 2016 and March 2022. The samples were sent to NVRI for diagnostic testing and were taken from flocks suspected of being infected with IBDV, MDV, or adenovirus. The bursal or spleen tissue obtained from one flock was pooled (from 2 to 12), homogenized in phosphate-buffered saline (4 mL PBS per gram tissue), and centrifuged at 4 °C 3500× g for 15 min. For the preparation of bursal tissue imprints on FTA cards, 5 mm diameter discs were cut and placed in a sterile tube and incubated with 1 mL of PBS for 1 h at room temperature. All post-treatment samples were stored below −65 °C for further examination.

2.2. Detection and Identification of IBDV

Viral RNA was extracted using an IndiSpin Pathogen Kit (Indical Bioscience, Germany) following the supplier’s instructions. The presence of IBDV was confirmed using the previously published real-time RT-PCR protocol [23]. The initial differentiation into vaccine and field IBDV strains was based on the partial amplification of the VP2 gene [24], followed by Sanger sequencing and sequence comparison to the vaccine strains. For the genotyping of field strains, the partial amplification of the VP1 gene was performed using the primers VP1.154F and VP1.998R. RT-PCR reaction was carried out using a one-step RT-PCR kit (Qiagen, Germany), according to the manufacturer’s guidelines and the following thermal conditions: RT at 50 °C for 30 min, PCR—initial denaturation at 95 °C for 15 min, followed by 35 cycles of amplification (denaturation 94 °C for 40 s, annealing at 57 °C for 1 min, and elongation at 72 °C for 1 min). The final extension was conducted at 72 °C for 7 min. Furthermore, the full-coding sequences of both genome segments (primers SegA_F/SegA0_R and SegB0_F/SegB0_R) of the selected strains were obtained using a SuperScript IV One-Step RT-PCR System with Platinum SuperFi DNA Polymerase (Invitrogen, Vilnius, Lithuania), according to the manufacturer’s instructions. The obtained amplicons after purification with QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) were cloned into the pJET1.2 vector (Thermo Scientific, Vilnius, Lithuania). The sequences of all the primers used in the study are listed in Table 1. All the obtained PCR products and recombinant plasmids were sequenced in both directions using a commercial service (Genomed, Warsaw, Poland).

2.3. Phylogenetic Analysis

The partial sequences of the VP2 and VP1 genes or the full coding sequences of the A and B segments of 180 IBDV reference strains representing different genotypes were downloaded from the GenBank database and included in the analyses (Supplemental Table S1). The ClustalW algorithm implemented in MEGAX software was used to align all sets of the sequence [25]. IQ-TREE software (version 1.6.12) was used both to estimate the best evolutionary model and to infer phylogenetic trees using the maximum likelihood algorithm, and confidence levels for the branches were determined with the Shimodaira–Hasegawa test and 1000 replicates of bootstrap [26]. The nucleotide identity was calculated using Geneious Prime 2022.1.1, while tree visualization was performed using the iTOL v6 online tool [27].

2.4. Virus Isolation

The virus isolation was performed using 10-day-old specific pathogen-free (SPF) embryonated eggs (Valo BioMedia, Osterholz-Scharmbeck, Germany) and the chorioallantoic membrane (CAM) route. Before inoculation, the tissue supernatant was filtered through a 0.45 µm membrane. After a 7-day incubation, the embryos and chorioallantoic membrane were harvested, homogenized, and stored below −65 °C.

3. Results

3.1. Molecular Detection, Genotyping, and Characterization of IBDV

The molecular survey revealed the presence of IBDV in 196 flocks, among which field and vaccine strains were detected in 52 and 144 flocks, respectively. The number of flocks with the presence of field IBDV accounted for 24.07% of the total surveyed (52/216). By year, the percentage of positive flocks was 12.8% (6/47) in 2016, 30.3% (20/60) in 2017, 33.3% (16/48) in 2018, 9.5% (2/20) in 2019, 29.4% (5/17) in 2020, 6.7% (1/14) in 2021, and 100% in 2022 (2/2). The detailed data on flocks where such strains were found are presented in Table 2. Genotyping analysis based on the partial sequence of both segments (Figure 1) showed that the detected Polish IBDV strains represent the A3B2 genotype, i.e., vvIBDV, and the reassortants of the A3B4 and A3B1 genotypes. The administrative location of the demonstrated genotypes is shown in Figure 2. In addition, in one case (strain H286/17), a serotype 2 strain was confirmed (Figure 1). The obtained sequences were deposited in the GenBank database (accession numbers presented in Table 2). The reassortants of the A3B4 genotype were the most abundant, and the survey conducted confirmed its presence in 27 flocks throughout the sampling period (n = 6 in 2016, n = 9 in 2017, n = 8 in 2018, n = 3 in 2020, and n = 1 in 2022). A total of 20 chicken flocks infected with very virulent IBDV (A3B2 genotype) were identified between 2017 and 2020 (Table 1, n = 9 in 2017, n = 8 in 2018, n = 1 in 2019, and n = 2 in 2020). In turn, two reassortant strains of the A3B1 genotype were confirmed in 2021 and 2022 in broiler flocks reared in western Poland (Figure 2, Kuyavian–Pomeranian and Greater Poland Voivodeships). For the three strains 97/1967/17, H286/17, and 68/19, the VP1 sequence was not obtained, and therefore genotyping is incomplete.
The phylogenetic analysis based on partial VP2 nucleotide sequences showed that the Polish strains clustered in three separate branches within genogroup A3, which were designated as A3.1, A3.2, and A3.3 (Figure 3), while for VP1, they clustered in three different genogroups: B1, B2, and B4 (Figure 1B). Cluster A3.1 grouped the reassortants of the A3B1 genotype, and cluster A3.2 gathered the very virulent A3B2 strains, while the collected strains in cluster A3.3 represented the A3B4 genotype, indicating separate evolution of the VP2 gene of these three Polish IBDV lineages despite belonging to the same genogroup A3.
The two Polish IBDV reassortants of genotype A3B1 showed relatively low similarity to each other, 97.1% and 98.6% for VP2 and VP1, respectively (Supplemental Table S2). This very likely points to two independent introductions of this virus in Poland. The 18/21/Poland/2021 strain had the highest nucleotide similarity with A3B1 reassortants reported by Mato et al. [19] circulating in Sweden, Germany, Belgium, and the Czech Republic in 2017–2019 (99.3–99.5% for partial VP2; the VP1 sequences analyzed had short overlapping regions; hence, their similarity was not determined; Supplemental Table S2), while strain 38/22/Poland/2022 was more similar to the German and Dutch strains from the survey conducted in 2021 by Legnardi et al. [18] (99.3–99.5% and 99.7% for VP2 and VP1, respectively; Supplemental Table S2).
The clade A3.2 was formed by the strains of genotype A3B2 (Figure 3); however, phylogenetic analysis showed that the very virulent strains both described in this paper and circulating in 2014–2015 were separately clustered, which may indicate subsequent introductions of vvIBDV (Figure 1A). This hypothesis is supported by the high homogeneity of this group of viruses at the nucleotide level, where the similarity for VP2 and VP1 genes was 98.4–100% and 99.1–100%, respectively. Whereas the identity for VP2 with other polish A3 strains was much lower and ranged from 94.3% to 96.4% for A3.3 and from 94.1% to 95.2% for A3.1. The similarity to the 2014–2015 vvIBDV strains was also low, at 96.2–97.3% and 97.2–97.9% for VP2 and VP1, respectively. Blast analysis for both VP2 and VP1 nucleotide sequences of A3B2 Polish strains showed that the Israeli ks strain and the resulting attenuated mb strain were the most similar, with identities of 97.5–98.4% and 98.8–99.5%, respectively. It should be noted that A3B2 infections were detected only in the chicken flocks reared in eastern Poland, which may suggest a potential direction of virus introduction.
The last group A3c clustered the strains of genotype A3B4, which were earlier reported in Poland and Finland [28,29]. The nucleotide similarity of the A3.3 strains for VP2 was 97.1–100% and for VP1 97.9–100%. The phylogenetic analysis exhibited that these strains branched into two separate clades (Figure 1A). Interestingly, the first clustered the strains from IBD outbreaks from 2011 to 2018, while the strains from 2014 to 2022 formed the second clade, indicating that this emergent sublineage now dominates in the field.
The molecular survey carried out in one of the samples confirmed the presence of a strain belonging to serotype 2 (H286/17), which has not yet been reported in Poland. It showed the highest nucleotide similarity of the VP2 gene to the strain of European origin (23/82), which was 85.2%. In addition, one of the detected strains (97/1967/17) was on the same branch of the phylogenetic tree as the previously detected vvIBDV strains in Poland; nevertheless, its genotype could not be fully determined, as VP1 amplification failed.
During the study, the full-length genome sequencing of the 10 selected strains representing three genotypes was also performed. All the exhibited amino acid changes in the tested strains are shown in Figure 4 and Figure 5. The 38/22/Poland/2022 strain representing the A3B1 genotype possessed all aa changes previously reported by Mato et al. [19], including D19, L74, V112 in VP5; L219, D254, N279, and T280 in VP2 (Figure 4) and S23, L275, D515, and V859 in VP1 (Figure 5). However, the analysis confirmed the presence of additional eight aa substitutions, but four of them were also found in the Belgian A3B1 reassortant chicken/4439_001/2020 (Accession no. MZ367373 and MZ367374), such as R133 in VP5, K359 in VP2, N787 and V951 in VP3; and A667 in VP1 [30], which showed that there were at least two lineages within this group of reassortants. Unfortunately, only three full genomic sequences of A3B1 strains are available in the GenBank database, making it difficult to determine their diversity at the genetic level.
In turn, the Polish A3B2 strains share some molecular signatures with ks and mb strain, including N279, N642, S745, and V990 in the polyprotein encoded by segment A, as well as S360 within the VP1 protein [31]. However, additional amino acid changes were observed in the Polish A3B2 strains, such as K221 and D254 within the antigenic epitopes of VP2 protein (PBC, PDE, and PFG loops, respectively), I608 in VP4, K923 in VP3, and D246 within VP1 (Figure 3 and Figure 4).
The strains of genotype A3B4 had the aa structure of polyprotein, which is typical for very virulent IBDV strains, except for the presence of threonine (T) at position 270 and valine (V) at position 990 (Figure 3). In turn, some of these strains had additional aa changes S79 in VP2 and I263 in VP1.
The phylogenetic analysis of the nucleotide sequences of the segments A (VP5-VP2-VP4-VP3) and B (VP1) also confirmed that the Polish strains belonged to the genotypes A3B1, A3B2, and A3B4 (Figure 6) and clustered into three different clades within genogroup 3.

3.2. Virus Isolation

The collected bursal samples (n = 40) were propagated using the chorioallantoic route on SPF embryonated eggs. All A3B4 (n = 22) strains were successfully isolated, and both embryo mortality between 3 and 6 dpi and macroscopic lesions, such as mottled-appearing necrosis in the liver and pale appearance of the heart, were noted during laboratory observation. Interestingly, during the isolation of the very virulent strains (n = 16), often neither mortality nor macroscopic changes were observed; moreover, in four cases, the virus could not be isolated. In turn, in the case of the two A3B1 reassortants, only strain 38/22/Poland/2022 was successfully isolated, and, as with the A3B2 strains, the virus did not cause mortality or lesions in the infected embryos.

4. Discussion

Poland is among the largest producer of chicken meat and eggs in the EU in recent years [32]. The high number and density of poultry flocks in some regions favor the spread of pathogens. On the other hand, extensive vaccination increases environmental pressure, which supports the selection of advantageous genetic changes and the emergence of new strains. IBDV infections pose a serious problem in poultry production worldwide due to direct or indirect losses. In Poland, the emergence of the vvIBDV was recognized at the end of 1991, the virus spread rapidly in the country leading to economic losses in both commercial and backyard farming [33]. A recent paper indicated the co-existence, for almost 30 years, of two IBDV lineages in the field, i.e., A3B2 and A3B4 genotypes [34]. Moreover, the A3B4 reassortants competed with the very virulent strains, becoming the prevalent lineage in Poland and disseminating to other countries. A similar situation is observed across Europe, hitherto dominated by vvIBDV, and now facing a wave of A3B1 IBDV infections [18,19]. Furthermore, the occurrence of a new A9B1 genotype was shown in Portugal [13] and antigenic variants in France [35]. The present study aimed to update the epidemiological situation of IBDV in Poland in order to detect potential threats to domestic poultry production.
A five-year molecular survey showed the presence of three genotypes of IBDV field strains, including the “old” A3B4 reassortants, and new A3B2 and A3B1, indicating the shift in the population of IBDV genetic lineages circulating in Poland. The results obtained established that the IBDVs of the A3B4 genotype have been continuously circulating in Poland since 1992, indicating the high fitness of this genetic lineage. The analysis showed further evolution of these strains (Figure 1 and Figure 5), highlighted by the bifurcation of the phylogenetic branch and the occurrence of additional aa alterations (Figure 3 and Figure 4). Most of the exhibited aa changes are individual; however, the presence of a serine at position 79 of VP2 and isoleucine at position 263 of VP1 was exhibited almost in all the strains, indicating the fixation of the previously resulting changes in subsequent generations of the virus progeny. Unfortunately, it is still unknown whether these changes affect the function of VP2 and VP1 proteins.
The next genotype of IBDV identified during the study was A3B2. Interestingly, these IBDVs represent newly introduced lineage, demonstrating that previously circulating lineage became extinct, or there was a strong decline in virus population size. The detected strain 97/1967/17 is likely to be the last identified representative of the previous vvIBDV lineage, as indicated by clustering together with their representatives, i.e., 75/11, 236/14, 72/15, and 20/15 (Figure 1A). The origin of this new A3B2 lineage in Poland is unknown. It should be added that there is no information on the occurrence of similar strains in Europe, and the absence of such strains in recent studies on numerous samples from western European countries suggests the opposite direction, especially given the availability of a very small number of such sequences in the GenBank database. This suspicion is also supported by the occurrence of these strains, which is limited to the eastern provinces of Poland (Figure 2B). Moreover, the phylogenetic analysis of the full-coding sequence revealed that the most closely related IBDV is the Israeli strain ks and the resulting attenuated mb strain. This mb strain is routinely used in Poland for immunoprophylaxis against IBD, which may suggest a potential origin of these strains. Nevertheless, this is contradicted by several data, the first being the presence of seven aa changes in the deduced sequence compared with the mb strain, including five in the polyprotein (Figure 3) and two in the viral polymerase (Figure 4). In addition, as a result of attenuation, two aa alterations were found in each of the two segments in the mb strain (T272 and T527; and N96 and A161 in segments A and B, respectively), whereas the Polish strain has only one (N96) from the listed changes [31]. Secondly, a vaccine containing the mb strain has been used in Poland since 2006, while the first field strains representing this genotype were found in 2017. It seems unlikely that the vaccine strain suddenly acquired such a high number of mutations after 10 years of use. Routine diagnostics carried out in our laboratory showed that the mb strain is one of the most stable vaccine strains, i.e., we did not record nucleotide changes in the hypervariable domain of the VP2 gene in the tested samples collected from vaccinated chickens. Another interesting aspect of this IBDV lineage is the presence of additional amino acid substitutions (K221, D254, and N279) located within PBC, PDE, and PFG loops of VP2. One of the detected aa changes, i.e., N279 was previously attributed to IBDV adaptation to growth in cell culture [36] or the attenuation of IBDV [37]. During laboratory examination, the detected field strains were propagated using SPF embryonated eggs. Interestingly, these very virulent IBDVs proliferated relatively poorly; moreover, the virus did not cause any lesions in the infected embryos. However, only further research will provide an answer as to whether the changes detected altered the virulence or antigenicity of these strains.
The last IBDV detected during the survey represents the reassortants of the A3B1 genotype, which are now predominant in northwestern Europe [18,19]. The presence of A3B1 reassortants in Poland indicates the continued spread of these viruses in central Europe, as they have been confirmed in the Czech Republic and Slovakia [38]. The performed genetic analysis showed that the detected strains exhibited relatively low nucleotide similarity and possessed several aa alterations, indicating two independent virus introductions. The demonstrated diversity of A3B1 lineage reassortants is surprising, as these strains have circulated in Europe for 5 years [19], and the estimated tMRCA indicates the time of emergence of these strains between 2015 and 2017 [18]. What is also surprising is the scale of the extent of this epidemic. The spread of these lineages in Europe is probably favored by the reduced virulence [19], resulting in a subclinical course of infection, which makes the proper diagnosis of the disease difficult. Moreover, these strains have a number of aa alterations in antigenic epitopes, which may favor evasion of the post-vaccination response. Previous studies reported that one of the observed aa changes (D254) resulted in altered reactivity with monoclonal antibodies (Mab5) of A4B1 genotype strains [39]. However, only studies of the efficacy of IBD immunoprophylaxis will confirm this theory.
In conclusion, the results obtained exhibited a shift in the genetic lineages of IBDV circulating in Poland. In addition, three different IBDV genotypes were demonstrated in the field, indicating a more complex epidemiological situation than before. The introduction of two genotypes carrying a number of aa substitutions within the antigenic determinants was found, raising the question of whether the vaccines used confer protection against their infection. In addition, we demonstrated the further spread of A3B1 reassortants in central Europe, showing the need for further monitoring studies in this region and an assessment of their impact on poultry welfare in the EU.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/v15020289/s1, Supplementary Table S1. List of reference IBDV strains used in phylogenetic analysis. Supplementary Table S2. Nucleotide similarity of partial VP2 and VP1 gene of IBDV strains.

Author Contributions

Conceptualization, A.P.; methodology, A.P. and K.D.-B.; investigation, A.P. and A.L.; data curation A.P. and A.L.; formal analysis, A.P., A.L. and K.D.-B.; writing—original draft preparation, A.P.; writing—review and editing, A.P., K.D.-B. and A.L.; visualization, A.P.; supervision, A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study because field samples were collected post-mortem by the veterinarian service.

Informed Consent Statement

Not applicable.

Data Availability Statement

The obtained genome sequences generated in this study were submitted to the GenBank database (https://www.ncbi.nlm.nih.gov/genbank/ accessed on 24 November 2022, under accession numbers OP978030 and OP978126).

Acknowledgments

We thank Katarzyna Skowronek and Paulina Sadurska for excellent technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hirai, K.; Funakoshi, T.; Nakai, T.; Shimakura, S. Sequential changes in the number of surface immunoglobulin-bearing B lymphocytes in infectious bursal disease virus-infected chickens. Avian Dis. 1981, 25, 484–496. [Google Scholar] [CrossRef]
  2. Dey, S.; Pathak, D.C.; Ramamurthy, N.; Maity, H.K.; Chellappa, M.M. Infectious bursal disease virus in chickens: Prevalence, impact, and management strategies. Vet. Med. 2019, 10, 85–97. [Google Scholar] [CrossRef] [Green Version]
  3. Dobos, P.; Hill, B.J.; Hallett, R.; Kells, D.T.; Becht, H.; Teninges, D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J. Virol. 1979, 32, 593–605. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Lejal, N.; Da Costa, B.; Huet, J.C.; Delmas, B. Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J. Gen. Virol. 2000, 81, 983–992. [Google Scholar] [CrossRef]
  5. Schnitzler, D.; Bernstein, F.; Muller, H.; Becht, H. The Genetic-Basis for the Antigenicity of the Vp2-Protein of the Infectious Bursal Disease Virus. J. Gen. Virol. 1993, 74, 1563–1571. [Google Scholar] [CrossRef]
  6. Van Loon, A.; de Haas, N.; Zeyda, I.; Mundt, E. Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J. Gen. Virol. 2002, 83, 121–129. [Google Scholar] [CrossRef]
  7. Von Einem, U.I.; Gorbalenya, A.E.; Schirrmeier, H.; Behrens, S.E.; Letzel, T.; Mundt, E. VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase. J. Gen. Virol. 2004, 85, 2221–2229. [Google Scholar] [CrossRef]
  8. Ye, C.; Wang, Y.; Zhang, E.; Han, X.; Yu, Z.; Liu, H. VP1 and VP3 Are Required and Sufficient for Translation Initiation of Uncapped Infectious Bursal Disease Virus Genomic Double-Stranded RNA. J. Virol. 2018, 92, e01345-17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Le Nouen, C.; Toquin, D.; Muller, H.; Raue, R.; Kean, K.M.; Langlois, P.; Cherbonnel, M.; Eterradossi, N. Different Domains of the RNA Polymerase of Infectious Bursal Disease Virus Contribute to Virulence. PLoS ONE 2012, 7, e28064. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Islam, M.R.; Nooruzzaman, M.; Rahman, T.; Mumu, T.T.; Rahman, M.M.; Chowdhury, E.H.; Eterradossi, N.; Muller, H. A unified genotypic classification of infectious bursal disease virus based on both genome segments. Avian Pathol. 2021, 50, 190–206. [Google Scholar] [CrossRef] [PubMed]
  11. Wang, Y.L.; Fan, L.J.; Jiang, N.; Gao, L.; Li, K.; Gao, Y.L.; Liu, C.J.; Cui, H.Y.; Pan, Q.; Zhang, Y.P.; et al. An improved scheme for infectious bursal disease virus genotype classification based on both genome-segments A and B. J. Integr. Agric. 2021, 20, 1372–1381. [Google Scholar] [CrossRef]
  12. Wang, W.; Huang, Y.; Zhang, Y.; Qiao, Y.; Deng, Q.; Chen, R.; Chen, J.; Huang, T.; Wei, T.; Mo, M.; et al. The emerging naturally reassortant strain of IBDV (genotype A2dB3) having segment A from Chinese novel variant strain and segment B from HLJ 0504-like very virulent strain showed enhanced pathogenicity to three-yellow chickens. Transbound. Emerg. Dis. 2021, 69, e566–e579. [Google Scholar] [CrossRef]
  13. Legnardi, M.; Franzo, G.; Tucciarone, C.M.; Koutoulis, K.; Duarte, I.; Silva, M.; Le Tallec, B.; Cecchinato, M. Detection and molecular characterization of a new genotype of infectious bursal disease virus in Portugal. Avian Pathol. 2022, 51, 97–105. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, W.Y.; Wang, X.M.; Gao, Y.L.; Qi, X.L. The Over-40-Years-Epidemic of Infectious Bursal Disease Virus in China. Viruses 2022, 14, 2253. [Google Scholar] [CrossRef] [PubMed]
  15. Thai, T.N.; Jang, I.; Kim, H.A.; Kim, H.S.; Kwon, Y.K.; Kim, H.R. Characterization of antigenic variant infectious bursal disease virus strains identified in South Korea. Avian Pathol. 2021, 50, 174–181. [Google Scholar] [CrossRef]
  16. Wang, W.; He, X.; Zhang, Y.; Qiao, Y.; Shi, J.; Chen, R.; Chen, J.; Xiang, Y.; Wang, Z.; Chen, G.; et al. Analysis of the global origin, evolution and transmission dynamics of the emerging novel variant IBDV (A2dB1b): The accumulation of critical aa-residue mutations and commercial trade contributes to the emergence and transmission of novel variants. Transbound. Emerg. Dis. 2022, 69, e2832–e2851. [Google Scholar] [CrossRef]
  17. Myint, O.; Suwanruengsri, M.; Araki, K.; Izzati, U.Z.; Pornthummawat, A.; Nueangphuet, P.; Fuke, N.; Hirai, T.; Jackwood, D.J.; Yamaguchi, R. Bursa atrophy at 28 days old caused by variant infectious bursal disease virus has a negative economic impact on broiler farms in Japan. Avian Pathol. 2021, 50, 6–17. [Google Scholar] [CrossRef]
  18. Legnardi, M.; Franzo, G.; Tucciarone, C.M.; Koutoulis, K.; Cecchinato, M. Infectious bursal disease virus in Western Europe: The rise of reassortant strains as the dominant field threat. Avian Pathol. 2022, 52, 25–35. [Google Scholar] [CrossRef] [PubMed]
  19. Mato, T.; Tatar-Kis, T.; Felfoldi, B.; Jansson, D.S.; Homonnay, Z.; Banyai, K.; Palya, V. Occurrence and spread of a reassortant very virulent genotype of infectious bursal disease virus with altered VP2 amino acid profile and pathogenicity in some European countries. Vet. Microbiol. 2020, 245, 108663. [Google Scholar] [CrossRef] [PubMed]
  20. Drissi Touzani, C.; Fellahi, S.; Fihri, O.F.; Gaboun, F.; Khayi, S.; Mentag, R.; Lico, C.; Baschieri, S.; El Houadfi, M.; Ducatez, M. Complete genome analysis and time scale evolution of very virulent infectious bursal disease viruses isolated from recent outbreaks in Morocco. Infect. Genet. Evol. 2020, 77, 104097. [Google Scholar] [CrossRef]
  21. Lachheb, J.; Jbenyeni, A.; Nsiri, J.; Larbi, I.; Ammouna, F.; El Behi, I.; Ghram, A. Full-length genome sequencing of a very virulent infectious bursal disease virus isolated in Tunisia. Poult. Sci. 2021, 100, 496–506. [Google Scholar] [CrossRef] [PubMed]
  22. Arowolo, O.A.; George, U.E.; Luka, P.D.; Maurice, N.A.; Atuman, Y.J.; Shallmizhili, J.J.; Shittu, I.; Oluwayelu, D.O. Infectious bursal disease in Nigeria: Continuous circulation of reassortant viruses. Trop. Anim. Health Prod. 2021, 53, 271. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, Y.Q.; Qi, X.L.; Gao, H.L.; Gao, Y.L.; Lin, H.; Song, X.Q.; Pei, L.; Wang, X.M. Comparative study of the replication of infectious bursal disease virus in DF-1 cell line and chicken embryo fibroblasts evaluated by a new real-time RT-PCR. J. Virol. Methods 2009, 157, 205–210. [Google Scholar] [CrossRef] [PubMed]
  24. Pikuła, A.; Domanska-Blicharz, K.; Cepulis, R.; Smietanka, K. Identification of infectious bursal disease virus with atypical VP2 amino acid profile in Latvia. J. Vet. Res. 2017, 61, 145–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef]
  26. Nguyen, L.T.; Schmidt, H.A.; von Haeseler, A.; Minh, B.Q. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2015, 32, 268–274. [Google Scholar] [CrossRef]
  27. Letunic, I.; Bork, P. Interactive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021, 49, W293–W296. [Google Scholar] [CrossRef] [PubMed]
  28. Pikuła, A.; Lisowska, A.; Jasik, A.; Perez, L.J. The Novel Genetic Background of Infectious Bursal Disease Virus Strains Emerging from the Action of Positive Selection. Viruses 2021, 13, 396. [Google Scholar] [CrossRef]
  29. Tammiranta, N.; Ek-Kommonen, C.E.; Rossow, L.; Huovilainen, A. Circulation of very virulent avian infectious bursal disease virus in Finland. Avian Pathol. 2018, 47, 520–525. [Google Scholar] [CrossRef]
  30. Van Borm, S.; Steensels, M.; Mathijs, E.; Vandenbussche, F.; van den Berg, T.; Lambrecht, B. Metagenomic sequencing determines complete infectious bronchitis virus (avian Gammacoronavirus) vaccine strain genomes and associated viromes in chicken clinical samples. Virus Genes 2021, 57, 529–540. [Google Scholar] [CrossRef]
  31. Lazarus, D.; Pasmanik-Chor, M.; Gutter, B.; Gallili, G.; Barbakov, M.; Krispel, S.; Pitcovski, J. Attenuation of very virulent infectious bursal disease virus and comparison of full sequences of virulent and attenuated strains. Avian Pathol. 2008, 37, 151–159. [Google Scholar] [CrossRef] [PubMed]
  32. Eurostat. Production of Meat: Poultry. Available online: https://ec.europa.eu/eurostat/databrowser/view/tag00043/default/table?lang=en (accessed on 24 October 2022).
  33. Minta, Z.; Daniel, A. Infectious bursal disease virus in Poland: Current situation and vaccinal control. In Proceedings of the 1st International Symposium on Infectious Bursal Disease and Chicken Infectious Anemia, Rauischholzhausen, Germany, 21–24 June 1994; pp. 208–214. [Google Scholar]
  34. Pikuła, A.; Śmietanka, K.; Perez, L.J. Emergence and expansion of novel pathogenic reassortant strains of infectious bursal disease virus causing acute outbreaks of the disease in Europe. Transbound. Emerg. Dis. 2020, 67, 1739–1744. [Google Scholar] [CrossRef] [PubMed]
  35. Molinet, A.; Courtillon, C.; Le Men, M.; Amenna-Bernard, N.; Retaux, C.; Leroux, A.; Lucas, P.; Blanchard, Y.; Nooruzzaman, M.; Islam, M.R.; et al. Full-Length Genome Sequence of a Novel European Antigenic Variant Strain of Infectious Bursal Disease Virus. Microbiol. Resour. Announc. 2022, 11, e0010222. [Google Scholar] [CrossRef] [PubMed]
  36. Lim, B.L.; Cao, Y.; Yu, T.; Mo, W.C. Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2. J. Virol. 1999, 73, 2854–2862. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Toroghi, R.; Kataria, J.M.; Verma, K.C.; Kataria, R.S.; Tiwari, A.K. Amino acid changes in the variable region of VP2 in three infectious bursal disease viruses with different virulence, originating from a common ancestor. Avian Pathol. 2001, 30, 667–673. [Google Scholar] [CrossRef] [PubMed]
  38. Mato, T.; Medveczki, A.; Kiss, I. Research Note: “Hidden” infectious bursal disease virus infections in Central Europe. Poult. Sci. 2022, 101, 101958. [Google Scholar] [CrossRef]
  39. Tomás, G.; Marandino, A.; Courtillon, C.; Amelot, M.; Keita, A.; Pikuła, A.; Hernández, M.; Hernández, D.; Vagnozzi, A.; Panzera, Y.; et al. Antigenicity, pathogenicity and immunosuppressive effect caused by a South American isolate of infectious bursal disease virus belonging to the “distinct” genetic lineage. Avian Pathol. 2019, 48, 245–254. [Google Scholar] [CrossRef]
Viruses 15 00289 g001a 550Viruses 15 00289 g001b 550
Figure 1. Maximum likelihood phylogenetic analysis of the truncated sequence of (A) VP2 (561nt) and (B) VP1 (427nt) genes according to Wang et al. rules [11]. Trees were constructed using GTR + F + I + G4 and TIM2e + G4 with 1000 bootstrap iterations for VP2 and VP1, respectively. The main IBDV genogroups are denoted with designation and colors, and the taxa name of the Polish strains characterized in the presented study are highlighted with yellow.
Figure 1. Maximum likelihood phylogenetic analysis of the truncated sequence of (A) VP2 (561nt) and (B) VP1 (427nt) genes according to Wang et al. rules [11]. Trees were constructed using GTR + F + I + G4 and TIM2e + G4 with 1000 bootstrap iterations for VP2 and VP1, respectively. The main IBDV genogroups are denoted with designation and colors, and the taxa name of the Polish strains characterized in the presented study are highlighted with yellow.
Viruses 15 00289 g001aViruses 15 00289 g001b
Viruses 15 00289 g002 550
Figure 2. Depiction of administrative areas in Poland where IBDV field strains belonging to A3B4 (A), A3B2 (B), and A3B1 (C) genotypes were detected.
Figure 2. Depiction of administrative areas in Poland where IBDV field strains belonging to A3B4 (A), A3B2 (B), and A3B1 (C) genotypes were detected.
Viruses 15 00289 g002
Viruses 15 00289 g003 550
Figure 3. Subtree for the genogroup A3, the clades for the Polish strains were denoted A3.1 in blue, A3.2 in red, and A3.3 in green, and the sequence AY368653 was outgroup (blue).
Figure 3. Subtree for the genogroup A3, the clades for the Polish strains were denoted A3.1 in blue, A3.2 in red, and A3.3 in green, and the sequence AY368653 was outgroup (blue).
Viruses 15 00289 g003
Viruses 15 00289 g004 550
Figure 4. Comparison of amino acid substitutions in viral proteins encoded by segment A between Polish and reference strains. Dots show identity with D6948. The amino acids forming the PBC (aa 219–224), PDE (aa 249–254), and PFG (aa 279–284) loops of the VP2 hypervariable domain are highlighted in blue, orange, and green, respectively. Abbreviations: vv—very virulent, A—alanine, D—aspartic acid, E—glutamic acid, F—phenylalanine, G—glycine, H—histidine, I –isoleucine, K—lysine, L—leucine, N—asparagine, S—serine, R—arginine, T—threonine, V—valine, Y—tyrosine.
Figure 4. Comparison of amino acid substitutions in viral proteins encoded by segment A between Polish and reference strains. Dots show identity with D6948. The amino acids forming the PBC (aa 219–224), PDE (aa 249–254), and PFG (aa 279–284) loops of the VP2 hypervariable domain are highlighted in blue, orange, and green, respectively. Abbreviations: vv—very virulent, A—alanine, D—aspartic acid, E—glutamic acid, F—phenylalanine, G—glycine, H—histidine, I –isoleucine, K—lysine, L—leucine, N—asparagine, S—serine, R—arginine, T—threonine, V—valine, Y—tyrosine.
Viruses 15 00289 g004
Viruses 15 00289 g005 550
Figure 5. Comparison of amino acid substitutions in viral proteins encoded by segment B between Polish and reference strains. Dots show identity with D6948, while dashes indicate the lack of available aa sequence. Abbreviations: vv—very virulent, trans—transitional IBDV, cv—classical virulent, A—alanine, D—aspartic acid, E—glutamic acid, F—phenylalanine, G—glycine, H-histidine, I—isoleucine, K—lysine, L-leucine, N—asparagine, S—serine, R—arginine, T—threonine, V—valine, W—tryptophan.
Figure 5. Comparison of amino acid substitutions in viral proteins encoded by segment B between Polish and reference strains. Dots show identity with D6948, while dashes indicate the lack of available aa sequence. Abbreviations: vv—very virulent, trans—transitional IBDV, cv—classical virulent, A—alanine, D—aspartic acid, E—glutamic acid, F—phenylalanine, G—glycine, H-histidine, I—isoleucine, K—lysine, L-leucine, N—asparagine, S—serine, R—arginine, T—threonine, V—valine, W—tryptophan.
Viruses 15 00289 g005
Viruses 15 00289 g006 550
Figure 6. Maximum likelihood phylogenetic analysis of full coding sequence of (A) segment A (3076 nt) and (B) B (2640 nt). Trees were constructed using GTR + F + I + G4 with 1000 bootstrap iterations. The main IBDV genogroups are denoted with designation and colors, and the taxa name of the Polish strains characterized in the presented study are highlighted with yellow.
Figure 6. Maximum likelihood phylogenetic analysis of full coding sequence of (A) segment A (3076 nt) and (B) B (2640 nt). Trees were constructed using GTR + F + I + G4 with 1000 bootstrap iterations. The main IBDV genogroups are denoted with designation and colors, and the taxa name of the Polish strains characterized in the presented study are highlighted with yellow.
Viruses 15 00289 g006
Table
Table 1. Primers used for amplification of IBDV in the study.
Table 1. Primers used for amplification of IBDV in the study.
PrimersPositions 1Nucleotide Sequence (5′→3′)Amplicon Size (bp)
Segment A
VP2-F512ACCTTCCAAGGAAGCCTGAGTG739
VP2-R1251ATCAGCTCGAAGTTGCTCACC
SegA0_F1GGATACGATCGGTCTGACCCCGGGGGAG3260
SegA0_R3260GGGGACCCGCGAACGGATCCAAT
Segment B
VP1.154F154TCAGCAGCGTTCGGCATAAAGC790
VP1.998R998TTTGTCCCTGCACCCTGCTTCA
SegB0_F1GGATACGATGGGTCTGACCCTCTG2827
SegB0_R2827GGGGGCCCCCGCAGGCGAAG
1 Numbering according to D6948 strain (segment A: AF240686, segment B: AF240687).
Table
Table 2. List of field strains circulated in Poland 2016–2022.
Table 2. List of field strains circulated in Poland 2016–2022.
StrainGenotypeCollectionChickenVaccinationGenBank Accession no.
DateAgeType(Vaccine Strain)VP1VP2
34/16A3B4February 20165wbroilerLIBDVOP978030OP978040
105/16A3B4April 201642dbroilerLukertOP978050OP978090
158/16BA3B4June 20166wbroilerNAOP978051OP978091
158/16CA3B4June 20164wbroilerNAOP978052OP978092
296/16A3B4November 201631dbroilerW2512 & CH/80OP978053OP978093
320/16A3B4December 20166wbroilerD78OP978031OP978041
5/17A3B4January 20174wbroilerLC75OP978054OP978094
22/17A3B4January 201718wlayerLIBDVOP978055OP978095
H287/17A0BxMarch 2017NAbroilerNAOP978056-
78/17A3B2March 201743dbroilerLC75OP978032OP978042
97/17A3B2April 2017NAbroilerD78OP978033OP978043
97/1967/17A3BxApril 2017NAbroilerNAOP978057-
115/17A3B2April 20175.5wbroilerGM97OP978058OP978096
117/17A3B2April 2017NAbroilerW2512 & D78OP978059OP978097
130/17K10A3B4April 201731dbroilerW2512 & CH/80OP978060OP978098
130/17K11A3B4April 201731dbroilerW2512 & CH/80OP978061OP978098
169/17A3B4May 201725dbroilerNAOP978061OP978099
179/17A3B4June 20179wlayerNAOP978062OP978100
182/17A3B4June 20176wbroilerFaragher 52/70OP978063OP978101
212/17A3B4June 2017NANANAOP978064OP978102
216/17A3B4June 2017NANAGM97OP978065OP978103
232/17A3B2July 20176wbroilerGM97OP978066OP978104
233/17A3B2July 20176wbroilerGM97OP978067OP978105
264/17A3B2August 201739dbroilerGM97 & CH/80OP978068OP978106
323/17A3B2October 201741dbroilerLIBDVOP978069OP978107
325/17A3B2October 201739dbroilerGM97OP978070OP978108
27/18A3B4February 201831dbroilerNAOP978071OP978109
35/18A3B4February 20185wbroilerNAOP978072OP978110
78/18A3B4March 20185wbroilerNAOP978073OP978111
104/18K5A3B2April 20185.5wbroilerNAOP978074OP978112
104/18K7A3B2April 20185wbroilerNAOP978074OP978112
127/18A3B2April 201849dbroilerNAOP978075OP978113
158/18A3B2May 201840dlayerNo vac1OP978076OP978114
191/18A3B2June 201832dbroilerGM97OP978077OP978115
252/18A3B2July 2018NAbroilerNAOP978078OP978116
344/18A3B4July 20186wlayerFaragher 52/70OP978079OP978117
394/18A3B2August 201832dbroilerNAOP97808OP978118
416/18A3B4September 201836dbroilerW2512 & LIBDVOP978034OP978044
417/18A3B4September 201832dbroilerW2512 & LIBDVOP978081OP978119
460/18A3B2October 201835dbroilerW2512OP978035OP978045
526/18A3B4November 20187wlayerCH/80OP978082OP978120
532/18A3B4November 20184.5wbroilerW2512OP978083OP978121
4/19A3B2January 20195wbroilerNAOP978036OP978046
68/19A3BxFebruary 2019NAbroilerGM97OP978084-
73/20A3B4April 20206wlayerD78OP978085OP978122
121/20A3B4May 202039dbroilerNo vac1OP978086OP978123
123/20A3B2May 20206wbroilerNAOP97808OP978124
134/20A3B4June 2020NAbroilerNAOP978037OP978047
222/20A3B2August 202035dbroilerNAOP978088OP978125
18/21A3B1August 202142dbroilerNAOP978089OP978126
38/22A3B1March 202231dbroilerLIBDVOP978038OP978048
90/22A3B4June 20224wlayer1/65/PVOP978039OP978049
d: days; w: weeks; NA: not available; No vac—no vaccination; 1 organic production; full-coding sequences are denoted in bold.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pikuła, A.; Lisowska, A.; Domańska-Blicharz, K. Epidemiology of Infectious Bursal Disease Virus in Poland during 2016–2022. Viruses 2023, 15, 289. https://doi.org/10.3390/v15020289

AMA Style

Pikuła A, Lisowska A, Domańska-Blicharz K. Epidemiology of Infectious Bursal Disease Virus in Poland during 2016–2022. Viruses. 2023; 15(2):289. https://doi.org/10.3390/v15020289

Chicago/Turabian Style

Pikuła, Anna, Anna Lisowska, and Katarzyna Domańska-Blicharz. 2023. "Epidemiology of Infectious Bursal Disease Virus in Poland during 2016–2022" Viruses 15, no. 2: 289. https://doi.org/10.3390/v15020289

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop